SEATTLE, May 5 /PRNewswire-FirstCall/ -- On Thursday, May 7, 2009, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the Company's 2009 first quarter achievements and financial results.
Conference Call Numbers Thursday, May 7 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time 1-888-561-1799 (US Participants) 1-480-629-9867 (International) Call-back numbers for post-listening available at 11:30 a.m. Eastern: 1-800-406-7325 (US Participants) 1 303 590 3030 (International) Passcode: 4066143#
Live audio webcast at http://www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.
Media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 E: firstname.lastname@example.org www.CellTherapeutics.com/press_room Investors Contact: Ed Bell T: 206.272.4345 Lindsey Jesch Logan T: 206.272.4347 F: 206.272.4434 E: email@example.com www.CellTherapeutics.com/investors
|SOURCE Cell Therapeutics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved